Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease.

Modulating immune function is a critical strategy in cancer and atherosclerosis treatments. For cancer, boosting or maintaining the immune system is crucial to prevent tumor growth. However, in vascular disease, mitigating immune responses can decrease inflammation and slow atherosclerosis progression. Anti-inflammatory therapy, therefore, presents a unique dilemma for cancer survivors: while it may decrease cardiovascular risk, it might also promote cancer growth and metastasis by suppressing the immune response. Senescence presents a potentially targetable solution to this challenge; senescence increases the risk of both cancer therapy resistance and vascular disease. Exercise, notably, shows promise in delaying this premature senescence, potentially improving cancer outcomes and lowering vascular disease risk post-treatment. This review focuses on the long-term impact of cancer therapies on vascular health. We underscore the importance of modulating senescence to balance cancer treatment's effectiveness and its vascular impact, and we emphasize investigating the role of exercise-mediated suppression of senescence in improving cancer survivorship.

Casso-Chapa, B., Vazquez Gonzlez, N. A., Le, N., Palaskas, N. L., Nead, K. T., Eutsey, L. P., ... Abe, J.

Casso-Chapa, Bernardo||Vazquez González, Norma Alicia||Le, Nhat-Tu||Palaskas, Nicolas L||Nead, Kevin T||Eutsey, Lydia P||Samanthapudi, Venkata SK||Osborn, Abigail M||Lee, Jonghae||Mejia, Gilbert||Hoang, Oanh||Lin, Steven H||Deswal, Anita||Herrmann, Joerg||Wang, Guangyu||Kirkland, James L||Krishnan, Sunil||Wehrens, Xander HT||Chini, Eduardo N||Yusuf, Syed Wamique||Iliescu, Cezar A||Jain, Abhishek||Burks, Jared K||Seeley, Erin||Lorenzi, Philip L||Chau, Khanh M||Ostos Mendoza, Keila Carolina||Grumbach, Isabella M||Brookes, Paul S||Hanssen, Nordin MJ||de Winther, Menno PJ||Yvan-Charvet, Laurent||Kotla, Sivareddy||Schadler, Keri||Abe, Jun-Ichi

Overview